Resultados da busca - Kristian Reich

Refinar Resultados
  1. 1
    The concept of psoriasis as a systemic inflammation: implications for disease management

    The concept of psoriasis as a systemic inflammation: implications for disease management por Kristian Reich

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Approach to managing patients with nail psoriasis

    Approach to managing patients with nail psoriasis por Kristian Reich

    Publicado em 2009
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  3. 3
    Psoriasis – New Insights Into Pathogenesis and Treatment

    Psoriasis – New Insights Into Pathogenesis and Treatment por Ulrich Mrowietz, Kristian Reich

    Publicado em 2009
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  4. 4
    Treatment goals in psoriasis

    Treatment goals in psoriasis por Kristian Reich, Ulrich Mrowietz

    Publicado em 2007
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  5. 5
    In touch with psoriasis: topical treatments and current guidelines

    In touch with psoriasis: topical treatments and current guidelines por G. M. Murphy, Kristian Reich

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  6. 6
    Interleukin‐17A: a unique pathway in immune‐mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis

    Interleukin‐17A: a unique pathway in immune‐mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis por Bruce Kirkham, Arthur Kavanaugh, Kristian Reich

    Publicado em 2013
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  7. 7
    Non‐adherence and measures to improve adherence in the topical treatment of psoriasis

    Non‐adherence and measures to improve adherence in the topical treatment of psoriasis por I. Zschocke, Ulrich Mrowietz, Eleni Karakasili, Kristian Reich

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  8. 8
    Nail psoriasis as a severity indicator: results from the PsoReal study

    Nail psoriasis as a severity indicator: results from the PsoReal study por Radtke, Anna Langenbruch, Kristian Reich, Matthias Augustin, Ines Schäfer

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    Assessing adherence factors in patients under topical treatment: development of the Topical Therapy Adherence Questionnaire (TTAQ)

    Assessing adherence factors in patients under topical treatment: development of the Topical Therapy Adherence Questionnaire (TTAQ) por I. Zschocke, Ulrich Mrowietz, Annett Lotzin, Eleni Karakasili, Kristian Reich

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  10. 10
    Co-morbidity and Age-related Prevalence of Psoriasis: Analysis of Health Insurance Data in Germany

    Co-morbidity and Age-related Prevalence of Psoriasis: Analysis of Health Insurance Data in Germany por Matthias Augustin, Kristian Reich, Gerd Glaeske, Ines Schaefer, Marc Alexander Radtke

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  11. 11
    Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey

    Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey por MA Radtke, Kristian Reich, Christine Blome, Stephan Jeff Rustenbach, Matthias Augustin

    Publicado em 2009
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  12. 12
    Long‐term efficacy and safety of secukinumab in the treatment of the multiple manifestations of psoriatic disease

    Long‐term efficacy and safety of secukinumab in the treatment of the multiple manifestations of psoriatic disease por Kristian Reich, Richard B. Warren, Laura C. Coates, Gabriele Di Comite

    Publicado em 2019
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  13. 13
    Promoter Polymorphisms of the Genes Encoding Tumor Necrosis Factor-α and Interleukin-1β are Associated with Different Subtypes of Psoriasis Characterized by Early and Late Disease Onset

    Promoter Polymorphisms of the Genes Encoding Tumor Necrosis Factor-α and Interleukin-1β are Associated with Different Subtypes of Psoriasis Characterized by Early and Late Disease... por Kristian Reich, Rotraut Mößner, Christine Neumann, Inke R. König, Götz Westphal, Andreas Ziegler

    Publicado em 2002
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3)

    Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3) por Andrew Blauvelt, Melinda Gooderham, Lars Iversen, Susan Ball, Lu Zhang, Noah Agada, Kristian Reich

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  15. 15
    Epidemiology and Comorbidity in Children with Psoriasis and Atopic Eczema

    Epidemiology and Comorbidity in Children with Psoriasis and Atopic Eczema por Matthias Augustin, Marc Alexander Radtke, Gerd Glaeske, Kristian Reich, Enno Christophers, Ines Schaefer, Arnd Jacobi

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  16. 16
    Quality of psoriasis care in Germany – results of the national study PsoHealth 2007

    Quality of psoriasis care in Germany – results of the national study PsoHealth 2007 por Matthias Augustin, Kristian Reich, Christine Reich, S. Purwins, Stephan Jeff Rustenbach, Ines Schäfer, Marc Alexander Radtke

    Publicado em 2008
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  17. 17
    A 52-Week Trial Comparing Briakinumab with Methotrexate in Patients with Psoriasis

    A 52-Week Trial Comparing Briakinumab with Methotrexate in Patients with Psoriasis por Kristian Reich, Richard Langley, Kim Papp, Jean‐Paul Ortonne, Kristina Unnebrink, Martin Kaul, Joaquin Valdes

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  18. 18
    Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest

    Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest por Kristian Reich, Ulrich Mrowietz, Marc Alexander Radtke, Diamant Thaçi, Stephan Jeff Rustenbach, C. Spehr, Matthias Augustin

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  19. 19
    Response of Psoriasis to Interleukin-10 is Associated with Suppression of Cutaneous Type 1 Inflammation, Downregulation of the Epidermal Interleukin-8/CXCR2 Pathway and Normalization of Keratinocyte Maturation

    Response of Psoriasis to Interleukin-10 is Associated with Suppression of Cutaneous Type 1 Inflammation, Downregulation of the Epidermal Interleukin-8/CXCR2 Pathway and Normalizati... por Kristian Reich, Volker Blaschke, Constance Maurer, Undine Lippert, Christine Neumann, Claus Garbe, Peter Middel, Götz Westphal

    Publicado em 2001
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  20. 20
    Combined Analysis of Polymorphisms of the Tumor Necrosis Factor-α and Interleukin-10 Promoter Regions and Polymorphic Xenobiotic Metabolizing Enzymes in Psoriasis

    Combined Analysis of Polymorphisms of the Tumor Necrosis Factor-α and Interleukin-10 Promoter Regions and Polymorphic Xenobiotic Metabolizing Enzymes in Psoriasis por Kristian Reich, Sabine Zipprich, Thomas Fuchs, Christine Neumann, Götz Westphal, Thomas Schulz, Michael Müller, Ernst Hallier

    Publicado em 1999
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: